HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Malignant atrophic papulosis (Köhlmeier-Degos): diagnosis, therapy and course].

Abstract
A 71-year-old male patient presented with malignant atrophic papulosis (Köhlmeier-Degos disease). He developed multiple distinctive cutaneous lesions. The histopathological findings showed an obliterated arteriole with a wedge-shaped area of ulcerated and necrobiotic dermis. Laboratory tests were within normal limits or not specific. Although the involvement of the gastrointestinal tract and other organs has been noted in approximately 60% of the reported cases, in this patient so far the skin seems to be the only involved site. There is no proven effective therapy for Köhlmeier-Degos disease. In our case treatment with pentoxifylline and aspirin led to healing of all skin lesions within 3 months. One year after beginning treatment, the patient showed neither new cutaneous lesions, nor any signs of systemic involvement. The combination of pentoxifylline and aspirin should be considered when planning treatment strategies for malignant atrophic papulosis.
AuthorsC Vicktor, U Schultz-Ehrenburg
JournalDer Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete (Hautarzt) Vol. 52 Issue 8 Pg. 734-7 (Aug 2001) ISSN: 0017-8470 [Print] Germany
Vernacular TitlePapulosis maligna atrophicans (Köhlmeier-Degos). Diagnose, Therapie, Verlauf.
PMID11544947 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Aspirin
  • Pentoxifylline
Topics
  • Aged
  • Aspirin (administration & dosage, therapeutic use)
  • Drug Therapy, Combination
  • Fibrinolytic Agents (administration & dosage, therapeutic use)
  • Follow-Up Studies
  • Humans
  • Male
  • Pentoxifylline (administration & dosage, therapeutic use)
  • Platelet Aggregation Inhibitors (administration & dosage, therapeutic use)
  • Skin (pathology)
  • Skin Diseases, Papulosquamous (diagnosis, drug therapy, pathology)
  • Syndrome
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: